$60.00
-4.54 (-7.03%)
Open$64.17
Previous Close$64.54
Day High$64.61
Day Low$60.00
52W High$97.97
52W Low$23.15
Volume—
Avg Volume47.0K
Market Cap211.30M
P/E Ratio—
EPS$-5.64
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
-79.3% upside
Current
$60.00
$60.00
Target
$12.40
$12.40
$7.31
$12.40 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.72M | 13.29M | 80.43M |
| Net Income | -7,179,370 | -3,779,499 | 27.17M |
| Profit Margin | -31.6% | -30.0% | 33.8% |
| EBITDA | -8,705,146 | -4,837,323 | 38.14M |
| Free Cash Flow | — | — | 15.33M |
| Rev Growth | +71.0% | +71.0% | -4.6% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |